SVRA
SVRA
NASDAQ · Biotechnology

Savara Inc

$4.96
-0.20 (-3.88%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +1,169.0% upside
Low Target $52.50
Average Target $62.94
High Target $80.97
Current Price $4.96
Current
$4.96
Target
$62.94
$52.50 $62.94 avg $80.97
Scenario Analysis
Bear Case
$52.50
958.5%
Low target
Base Case
$62.94
+1,169.0%
Avg target
Bull Case
$80.97
+1,532.5%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$7.01
-29.2% from high
52-Week Low
$1.89
+162.4% from low
Target vs 52W High
$62.94
+798.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%